Back to company

NORDIC PHARMACEUTICALS ApS: Financial statements 2024

CVR: 27430015

NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity amounted to DKK -1,152,541. The company had 2 employees in the financial year.

Gross Profit
-2,243,265 kr.
Profit/Loss
-2,664,416 kr.
Equity
-1,152,541 kr.
Total Assets
22,117 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--2.2 mio.-2.7 mio.-1.2 mio.2
2023-552 t.9 t.1.5 mio.2
2022-779 t.84 t.1.5 mio.2
2021-653 t.71 t.1.4 mio.2
2020-602 t.58 t.1.3 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDIC PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

NORDIC PHARMACEUTICALS ApS: The 2023 annual report is outJul 12, 2024

NORDIC PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 551,900, and the net result was DKK 9,351.

About NORDIC PHARMACEUTICALS ApS

NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 3 employees. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity amounted to DKK -1,152,541.